Edgewise Therapeutics grants stock options and restricted stock units to two new employees
EWTX•Edgewise Therapeutics granted two new non-executive employees options to purchase 17,250 common shares and restricted stock units covering 8,626 shares on October 30, 2026.
1. Inducement awards
The awards were granted under Edgewise Therapeutics’ 2024 Inducement Equity Incentive Plan. Options vest 25% on each employee’s first employment anniversary, followed by monthly vesting of 1/48th of the shares; restricted stock units vest 25% on each of the first four grant-date anniversaries. All vesting requires continued service.
